FBN3
Basic information
Region (hg38): 19:8065402-8149592
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FBN3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 184 | 51 | 238 | |||
missense | 473 | 63 | 47 | 583 | ||
nonsense | 12 | 12 | ||||
start loss | 0 | |||||
frameshift | 9 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
splice region | 18 | 41 | 16 | 75 | ||
non coding | 81 | 36 | 119 | |||
Total | 0 | 0 | 506 | 329 | 134 |
Variants in FBN3
This is a list of pathogenic ClinVar variants found in the FBN3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-8065983-G-T | FBN3-related disorder | Likely benign (Jan 12, 2024) | ||
19-8065992-C-T | Flexion contracture | Uncertain significance (Jul 20, 2023) | ||
19-8065993-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
19-8065999-G-A | not specified | Uncertain significance (Dec 15, 2022) | ||
19-8066017-C-T | not specified | Uncertain significance (Jul 05, 2023) | ||
19-8066028-C-T | See cases • not specified | Likely benign (Jun 28, 2022) | ||
19-8066029-G-A | not specified | Uncertain significance (Jul 14, 2023) | ||
19-8066045-C-A | Likely benign (Aug 06, 2023) | |||
19-8066049-C-T | Uncertain significance (Aug 30, 2023) | |||
19-8066078-G-A | Likely benign (Jan 04, 2022) | |||
19-8066082-C-T | Uncertain significance (May 11, 2022) | |||
19-8066096-GC-TT | Uncertain significance (Jul 19, 2022) | |||
19-8066097-C-G | not specified | Uncertain significance (Dec 20, 2023) | ||
19-8066097-C-T | not specified | Uncertain significance (May 31, 2023) | ||
19-8066098-G-A | Uncertain significance (Apr 01, 2022) | |||
19-8066119-C-T | FBN3-related disorder | Benign (Dec 11, 2023) | ||
19-8066120-G-A | Likely benign (Nov 18, 2023) | |||
19-8066122-G-A | Uncertain significance (Aug 10, 2022) | |||
19-8066125-C-T | Uncertain significance (Dec 07, 2022) | |||
19-8066126-G-A | Likely benign (Nov 27, 2023) | |||
19-8066127-A-G | not specified | Uncertain significance (Nov 04, 2023) | ||
19-8066132-G-A | Likely benign (Sep 21, 2023) | |||
19-8066136-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
19-8066137-G-A | Uncertain significance (Jun 09, 2022) | |||
19-8066143-G-A | Likely benign (Nov 30, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FBN3 | protein_coding | protein_coding | ENST00000600128 | 63 | 84445 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.44e-42 | 1.00 | 125369 | 0 | 379 | 125748 | 0.00151 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.958 | 1653 | 1.77e+3 | 0.936 | 0.000117 | 18370 |
Missense in Polyphen | 595 | 658.55 | 0.9035 | 7325 | ||
Synonymous | -0.0775 | 725 | 722 | 1.00 | 0.0000510 | 5387 |
Loss of Function | 4.19 | 90 | 144 | 0.624 | 0.00000760 | 1585 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00541 | 0.00528 |
Ashkenazi Jewish | 0.000310 | 0.000298 |
East Asian | 0.00197 | 0.00190 |
Finnish | 0.000617 | 0.000601 |
European (Non-Finnish) | 0.00145 | 0.00142 |
Middle Eastern | 0.00197 | 0.00190 |
South Asian | 0.00165 | 0.00160 |
Other | 0.00181 | 0.00179 |
dbNSFP
Source:
- Function
- FUNCTION: Fibrillin-3: Fibrillins are structural components of 10- 12 nm extracellular calcium-binding microfibrils, which occur either in association with elastin or in elastin-free bundles. Fibrillin-containing microfibrils provide long-term force bearing structural support. {ECO:0000269|PubMed:14962672}.;
- Pathway
- Hypothesized Pathways in Pathogenesis of Cardiovascular Disease;Extracellular matrix organization;Elastic fibre formation
(Consensus)
Recessive Scores
- pRec
- 0.135
Intolerance Scores
- loftool
- 0.0141
- rvis_EVS
- 7.07
- rvis_percentile_EVS
- 99.89
Haploinsufficiency Scores
- pHI
- 0.0992
- hipred
- N
- hipred_score
- 0.427
- ghis
- 0.404
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.123
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Gene ontology
- Biological process
- Cellular component
- extracellular matrix;collagen-containing extracellular matrix
- Molecular function
- extracellular matrix structural constituent;calcium ion binding